Market data loadingS&P 500--NASDAQ--Data as of latest ETNo timestamp

United Therapeutics Corporation (UTHR) Profit Margins

Over the twelve months to 2026-06-30, United Therapeutics Corporation (UTHR) had gross margin 86.1%, operating margin 44.4%, net margin 41.6%, free cash flow margin 34.4%, according to EquiReason's reading of its SEC filings.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

UTHRUnited Therapeutics CorporationFollow UTHR — free
Drug Manufacturers - Specialty & Generic · Healthcare
—
Price chart with a free account
Market cap
25.2B
P/E TTM
21.0
Dividend yield
—
52-week
—
Next earnings
4 Nov, in 11 days
LineFY2010
Dec 10		FY2011
Dec 11		FY2012
Dec 12		FY2013
Dec 13		FY2014
Dec 14		FY2015
Dec 15		FY2016
Dec 16		FY2017
Dec 17		FY2018
Dec 18		FY2019
Dec 19		FY2020
Dec 20		FY2021
Dec 21		FY2022
Dec 22		FY2023
Dec 23		FY2024
Dec 24		FY2025
Dec 25		TTM
Jun 26		Trend
Gross margin88.6%87.8%85.9%87.4%89.5%95.3%95.5%93.9%87.8%91.9%92.7%92.7%92.2%88.9%89.2%87.9%86.1%
Operating margin28.9%42.8%46.0%26.2%41.8%47.7%66.4%47.2%49.5%-12.9%40.0%33.0%50.6%50.9%47.9%46.9%44.4%
Net margin17.9%29.3%33.2%15.6%26.4%44.5%44.6%24.2%36.2%-7.2%34.7%28.2%37.6%42.3%41.5%41.9%41.6%
FCF margin32.5%28.8%23.1%35.2%23.9%22.7%37.9%22.5%36.5%-20.0%46.9%28.3%34.3%31.1%36.6%32.4%34.4%

USD billions · SEC XBRL

United Therapeutics Corporation — questions

What is United Therapeutics Corporation's gross margin?
86.1% over the twelve months to 2026-06-30.
What is United Therapeutics Corporation's operating margin?
44.4% over the twelve months to 2026-06-30.
What is United Therapeutics Corporation's net profit margin?
41.6% over the twelve months to 2026-06-30.

Every figure on this page comes from United Therapeutics Corporation's own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.